Organisation paid for research Program year 2025 Source: CMS Open Payments

Gcga Physicians Inc.

Neither a doctor nor a teaching hospital

Research payments

$395,219

52 payments

Through program year 2025, Gcga Physicians Inc. is reported as receiving $395,219 in research payments, across 52 payments.

By program year

7 rows

Year	Kind	Amount	Payments
2025	Research	$2,595	1
2024	Research	$60,622	1
2023	Research	$125,003	2
2022	Research	$45,241	5
2021	Research	$5,624	1
2020	Research	$5,306	5
2019	Research	$150,829	37

Breakdown

Who paid Research payments · program years 2019–2025

Celgene Corporation $233,461 9 payments
AbbVie, Inc. $138,534 31 payments
Janssen Research & Development, LLC $23,224 12 payments

Studies the money was for Research payments · program years 2019–2025

Phase III CC-93538 Treat-Through (CC-93538-EE-001) Wk24 PE Primary - A Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and Long-term Controlled Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolesc $187,331 3 payments
M14-234 $57,371 8 payments
M14-033 $32,907 9 payments
Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Protocol to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis $17,601 11 payments
Phase III CC-93538 Treat-Through (CC-93538-EE-001) Wk48 Primary - A Multi-Center, Multi-National, Randomized, Double-Blind, Placebo-Controlled Induction and Long-term Controlled Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent $17,481 1 payment
M14-533 $13,312 7 payments
M14-115 $11,696 2 payments
M14-431 $10,651 2 payments
M14-433 $10,103 1 payment
PhIII Yellowstone Induction Study # 1 OZANIMOD in Moderate to Severe CD (RPC01-3201) $9,584 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.